Studies have shown that PD-L1 expression is regulated by specific epigenetic enzymes, such as METTL3, the “writer” of m6A, which increases PD-L1 mRNA expression, promoting bladder cancer immune escape (175). Here, CD274 is linked to urinary bladder cancer.